PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Ethenzamide→

Ethenzamide PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
938-73-8
Molecular formula
C9H11NO2
Molecular weight
165.19 g/mol
Drug class
Salicylamide-derived non-steroidal analgesic and antipyretic
Mechanism of action
The precise mechanism is not completely established. Ethenzamide has analgesic and antipyretic activity; experimental studies suggest spinal and central actions, including antagonism at 5-HT2B receptors. Unlike classical salicylates, it has shown little or no direct inhibition of COX-1 or COX-2 in some studies.
Indications / reported uses
  • Used as an analgesic and antipyretic, commonly in combination products, in countries where ethenzamide is authorised.

Sources: https://www.ncbi.nlm.nih.gov/mesh/67018935 · https://pubchem.ncbi.nlm.nih.gov/compound/Ethenzamide · https://www.jstage.jst.go.jp/article/bpb/43/5/43_b19-01050/_article/-char/en · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Ethenzamide PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ethenzamide Permitted Daily Exposure (PDE) report (the Ethenzamide PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ethenzamide Occupational Exposure Limit (OEL) report (the Ethenzamide OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.